In diabetic nephropathy, miR-223 is downregulated, and miR-223-3p has been shown to mediate the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway, indicating protective mechanisms against diabetic kidney disease [117,118]. Here, STAT3 is linked to diabetic kidney disease.